Clinical trial for Alcohol Use Disorder
Official title Better Experiences in Substance Treatment: A Brief Alcohol-focused Intervention Tailored for Patients in Opioid Agonist Treatment
ClinicalTrials.gov ID: NCT07342504
What this study is testing
- What it's testing
- The study checks if the program is doable and liked by patients, and looks at early signs it might help reduce drinking.
- Who it's for
- Adults who are taking prescribed buprenorphine for opioid use and are currently drinking alcohol.
- What's involved
- Participants will receive a short, opioid‑aware alcohol counseling session and may have a few follow‑up visits or phone calls to track their drinking.
- Time commitment
- The study lasts a few weeks, with a brief initial visit and a short follow‑up to review progress.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Participants must be taking prescribed buprenorphine for at least 2 weeks
- Participants must be 18 years or older.
- Meet DSM-5 criteria for alcohol use disorder (AUD)
- Participants must report alcohol use ≥ 1 day/week on average in the past 28 days
- Participants must be able to read simple English
You likely can't join if
- Currently receiving formal alcohol use treatment.
- Currently experiencing psychosis
The study team makes the final eligibility decision.
Where it is enrolling
- Notre Dame, Indiana, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Notre Dame, Indiana, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.